131 related articles for article (PubMed ID: 23190425)
1. Impact of TAVI on mitral regurgitation: a prospective echocardiographic study.
Giordana F; Capriolo M; Frea S; Marra WG; Giorgi M; Bergamasco L; Omedè PL; Sheiban I; D'Amico M; Bovolo V; Salizzoni S; La Torre M; Rinaldi M; Marra S; Gaita F; Morello M
Echocardiography; 2013 Mar; 30(3):250-7. PubMed ID: 23190425
[TBL] [Abstract][Full Text] [Related]
2. Mitral regurgitation in patients referred for transcatheter aortic valve implantation using the Edwards Sapien prosthesis: mechanisms and early postprocedural changes.
Hekimian G; Detaint D; Messika-Zeitoun D; Attias D; Iung B; Himbert D; Brochet E; Vahanian A
J Am Soc Echocardiogr; 2012 Feb; 25(2):160-5. PubMed ID: 22071307
[TBL] [Abstract][Full Text] [Related]
3. Influence of CoreValve ReValving System implantation on mitral valve function: an echocardiographic study in selected patients.
De Chiara B; Moreo A; De Marco F; Musca F; Oreglia J; Lobiati E; Bruschi G; Belli O; Mauri F; Klugmann S
Catheter Cardiovasc Interv; 2011 Oct; 78(4):638-44. PubMed ID: 21805556
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter aortic valve implantation in patients with concomitant mitral and tricuspid regurgitation.
Hutter A; Bleiziffer S; Richter V; Opitz A; Hettich I; Mazzitelli D; Ruge H; Lange R
Ann Thorac Surg; 2013 Jan; 95(1):77-84. PubMed ID: 23063197
[TBL] [Abstract][Full Text] [Related]
5. Changes in mitral regurgitation after transcatheter aortic valve implantation.
Tzikas A; Piazza N; van Dalen BM; Schultz C; Geleijnse ML; van Geuns RJ; Galema TW; Nuis RJ; Otten A; Gutierrez-Chico JL; Serruys PW; de Jaegere PP
Catheter Cardiovasc Interv; 2010 Jan; 75(1):43-9. PubMed ID: 19739261
[TBL] [Abstract][Full Text] [Related]
6. Tricuspid but not Mitral Regurgitation Determines Mortality After TAVI in Patients With Nonsevere Mitral Regurgitation.
Amat-Santos IJ; Castrodeza J; Nombela-Franco L; Muñoz-García AJ; Gutiérrez-Ibanes E; de la Torre Hernández JM; Córdoba-Soriano JG; Jiménez-Quevedo P; Hernández-García JM; González-Mansilla A; Ruano J; Tobar J; Del Trigo M; Vera S; Puri R; Hernández-Luis C; Carrasco-Moraleja M; Gómez I; Rodés-Cabau J; San Román JA
Rev Esp Cardiol (Engl Ed); 2018 May; 71(5):357-364. PubMed ID: 29079280
[TBL] [Abstract][Full Text] [Related]
7. The beneficial effects of TAVI in mitral insufficiency.
Costantino MF; Dores E; Innelli P; Matera A; Santillo V; Violini R; Fiorilli R; Cappabianca G; Marraudino N; Picano E; Tarsia G
Cardiovasc Ultrasound; 2015 Dec; 13():49. PubMed ID: 26714887
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of echocardiographic criteria for transcatheter aortic valve implantation without balloon predilation: a single-center experience.
Islas F; Almería C; García-Fernández E; Jiménez P; Nombela-Franco L; Olmos C; Marcos-Alberca P; Cuadrado A; Fernández-Ortiz A; Macaya C; Pérez de Isla L
J Am Soc Echocardiogr; 2015 Apr; 28(4):423-9. PubMed ID: 25670008
[TBL] [Abstract][Full Text] [Related]
9. Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation.
D'Onofrio A; Gasparetto V; Napodano M; Bianco R; Tarantini G; Renier V; Isabella G; Gerosa G
Eur J Cardiothorac Surg; 2012 Jun; 41(6):1271-6; discussion 1276-7. PubMed ID: 22219481
[TBL] [Abstract][Full Text] [Related]
10. Predictors of 1-year mortality in patients with aortic regurgitation after transcatheter aortic valve implantation: an analysis from the multicentre German TAVI registry.
Abdel-Wahab M; Zahn R; Gerckens U; Linke A; Sievert H; Schäfer U; Kahlert P; Hambrecht R; Sack S; Hoffmann E; Senges J; Schneider S; Richardt G;
Heart; 2014 Aug; 100(16):1250-6. PubMed ID: 24895354
[TBL] [Abstract][Full Text] [Related]
11. Effect of aortic valve replacement for aortic stenosis on severity of mitral regurgitation.
Vanden Eynden F; Bouchard D; El-Hamamsy I; Butnaru A; Demers P; Carrier M; Perrault LP; Tardif JC; Pellerin M
Ann Thorac Surg; 2007 Apr; 83(4):1279-84. PubMed ID: 17383327
[TBL] [Abstract][Full Text] [Related]
12. Long-term Doppler hemodynamics and effective orifice areas of Edwards SAPIEN and medtronic CoreValve prostheses after TAVI.
Spethmann S; Dreger H; Baldenhofer G; Pflug E; Sanad W; Stangl V; Baumann G; Grubitzsch H; Sander M; Stangl K; Laule M; Knebel F
Echocardiography; 2014 Mar; 31(3):302-10. PubMed ID: 24111700
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of mitral regurgitation by an integrated 2D echocardiographic approach in patients undergoing transcatheter aortic valve replacement.
Jansen R; Wind AM; Cramer MJ; Nijhoff F; Agostoni P; Ramjankhan FZ; Suyker WJ; Stella PR; Chamuleau SAJ
Int J Cardiovasc Imaging; 2018 Aug; 34(8):1193-1204. PubMed ID: 29524077
[TBL] [Abstract][Full Text] [Related]
14. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction.
Clavel MA; Webb JG; Rodés-Cabau J; Masson JB; Dumont E; De Larochellière R; Doyle D; Bergeron S; Baumgartner H; Burwash IG; Dumesnil JG; Mundigler G; Moss R; Kempny A; Bagur R; Bergler-Klein J; Gurvitch R; Mathieu P; Pibarot P
Circulation; 2010 Nov; 122(19):1928-36. PubMed ID: 20975002
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular global systolic longitudinal deformation and prognosis 1 year after femoral and apical transcatheter aortic valve implantation.
Løgstrup BB; Andersen HR; Thuesen L; Christiansen EH; Terp K; Klaaborg KE; Poulsen SH
J Am Soc Echocardiogr; 2013 Mar; 26(3):246-54. PubMed ID: 23306032
[TBL] [Abstract][Full Text] [Related]
16. Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation.
O'Sullivan CJ; Stortecky S; Bütikofer A; Heg D; Zanchin T; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Blöchlinger S; Carrel T; Meier B; Zbinden S; Wenaweser P; Windecker S
Circ Cardiovasc Interv; 2015 Feb; 8(2):e001895. PubMed ID: 25657315
[TBL] [Abstract][Full Text] [Related]
17. Mitral regurgitation prior to transcatheter aortic valve implantation influences survival but not symptoms.
Boerlage-van Dijk K; Wiegerinck EM; Takama T; Koch KT; Vis MM; de Mol BA; Piek JJ; Bouma BJ; Baan J
Int J Cardiol; 2016 Feb; 204():95-100. PubMed ID: 26655549
[TBL] [Abstract][Full Text] [Related]
18. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter aortic implantation of the Edwards-SAPIEN bioprosthesis: insights on early benefit of TAVI on mitral regurgitation.
Samim M; Stella PR; Agostoni P; Kluin J; Ramjankhan F; Sieswerda G; Budde R; der Linden Mv; Samim M; Hillaert M; van Herwerden L; Doevendans PA; van Belle E
Int J Cardiol; 2011 Oct; 152(1):124-6. PubMed ID: 21840071
[No Abstract] [Full Text] [Related]
20. Hemodynamic impact and outcome of permanent pacemaker implantation following transcatheter aortic valve implantation.
Biner S; Michowitz Y; Leshem-Rubinow E; Topilsky Y; Ben-Assa E; Shimiaie J; Banai S; Keren G; Steinvil A; Finkelstein A
Am J Cardiol; 2014 Jan; 113(1):132-7. PubMed ID: 24210334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
